|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/51 | |
| A61K 47/34 | |||
| A61K 47/42 | |||
| A61P 35/00 | |||
| C08G 64/18 | |||
| C08G 64/30 | |||
| C08G 63/64 | |||
| C08G 63/688 | |||
| A61K 47/55 | |||
| A61K 47/60 | |||
| A61K 47/64 | |||
| A61K 47/69 | |||
| A61K 47/68 | |||
| A61K 47/62 |
| (11) | Number of the document | 3421519 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17759282.1 |
| Date of filing the European patent application | 2017-03-03 | |
| (97) | Date of publication of the European application | 2019-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2017/075529 |
| Date | 2017-03-03 |
| (87) | Number | WO 2017/148431 |
| Date | 2017-09-08 |
| (30) | Number | Date | Country code |
| 201610123977 | 2016-03-04 | CN |
| (72) |
MENG,Fenghua, CN
ZOU, Yan, CN
ZHONG, Zhiyuan, CN
YUAN, Jiandong, CN
|
| (73) |
BrightGene Bio-Medical Technology Co., Ltd.,
Building C25, No. 218, Xinghu Street,, Bio-Bay Suzhou Industrial Park Suzhou, Jiangsu 215123,
CN
|
| (54) | OVARIAN CANCER SPECIFICALLY TARGETED BIODEGRADABLE AMPHIPHILIC POLYMER, POLYMER VESICLE PREPARED THEREBY AND USE THEREOF |
| OVARIAN CANCER SPECIFICALLY TARGETED BIODEGRADABLE AMPHIPHILIC POLYMER, POLYMER VESICLE PREPARED THEREBY AND USE THEREOF |